The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

Anna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, Sònia Solé-Sánchez, Elisabet Megías-Roda, Héctor Pérez-Montoyo, Patricia Jauregui, Marc Yeste-Velasco, Mariana Gómez-Ferreria, Tatiana Erazo, Elisabet Ametller, Leire Recalde-Percaz, Núria Moragas-Garcia, Aleix Noguera-Castells, Mario Mancino, Teresa Morán, Ernest Nadal, José Alfón, Carles Domènech, Pere GasconJose M. Lizcano, Gemma Fuster*, Paloma Bragado

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences